Invention Grant
- Patent Title: Intraocular drug delivery device and associated methods
-
Application No.: US15590868Application Date: 2017-05-09
-
Publication No.: US09877973B2Publication Date: 2018-01-30
- Inventor: Balamurali K. Ambati , Bruce K. Gale , Srinivas Rao Chennamaneni
- Applicant: University of Utah Research Foundation
- Applicant Address: US UT Salt Lake City
- Assignee: University of Utah Research Foundation
- Current Assignee: University of Utah Research Foundation
- Current Assignee Address: US UT Salt Lake City
- Agency: Thorpe North & Western, LLP
- Main IPC: A61M31/00
- IPC: A61M31/00 ; A61K31/573 ; A61K9/00 ; A61K9/20

Abstract:
An intraocular active agent delivery device can include an active agent homogenously combined with a biodegradable active agent matrix such that the entire delivery device is homogenous. The homogenous delivery device can have a shape and size to fit within a lens capsule or ciliary sulcus of an eye and provide a therapeutically effective amount of the active agent to the eye. The biodegradable active agent matrix can be formulated to provide sustained release of the therapeutically effective amount of the active agent during a release period. In some examples, the active agent can include dexamethasone.
Public/Granted literature
- US20170239272A1 INTRAOCULAR DRUG DELIVERY DEVICE AND ASSOCIATED METHODS Public/Granted day:2017-08-24
Information query